Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands
Sara Sattin(University of Milan), Giorgio Colombo(University of Pavia), Marco Rusnati(Consorzio Interuniversitario per le Biotecnologie), Anna Bernardi(University of Milan), Mike Moses(National Cancer Institute), Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), Laura Morelli(University of Milan), Gerolamo Vettoretti(Institute of Chemistry of Molecular Recognition), Alessia Lopergolo(Fondazione IRCCS Istituto Nazionale dei Tumori), Elisabetta Moroni, Thomas L. Prince(National Cancer Institute), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Abbey D. Zuehlke(National Cancer Institute), Len Neckers(National Institutes of Health), Jiahui Tao(University of California, San Francisco), David A. Agard(University of California, San Francisco), Kristin Beebe(Center for Cancer Research), Toshiki Kijima(Dokkyo Medical University), Antonella Bugatti(University of Brescia)
Cited by 70
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Targeting the dynamic HSP90 complex in cancer
|Nature reviews. Cancer|2010|1.5k
Characterization of oligonucleotide transport into living cells.
|Proceedings of the National Academy of Sciences|1989|740
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
Multivalent glycoconjugates as anti-pathogenic agents
|Chemical Society Reviews|2012|534